Table 1.
Baseline Characteristics
| Limited-stage (I–IIA) (n = 28) | Advanced-stage (IIB–IV) (n = 20) | |
|---|---|---|
| Age (y), median (range) | 35 (18–73) | 36.5 (18–84) |
| Male | 15 (54) | 13 (65) |
| Female | 13 (46) | 7 (35) |
| Histological subtype | ||
| Nodular sclerosis | 18 (64) | 16 (80) |
| Mixed cellularity | 5 (18) | 2 (10) |
| Lymphocyte-rich | 1 (4) | 1 (5) |
| Lymphocyte-depleted | 0 | 0 |
| Unclassified | 4 (14) | 1 (5) |
| Ann Arbor stage | ||
| I | 6 (21) | - |
| II | 22 (79) | 5 (25) |
| III | - | 4 (11) |
| IV | - | 11 (55) |
| B-symptoms | 0 (0) | 14 (70) |
| Bulky disease | 7 (25) | 1 (5) |
| >2 nodal sites | 15 (54) | 19 (95) |
| Erythrocyte sedimentation rate ≥50 mm | 1 (4) | 13 (65) |
| Age >45 y | 8 (29) | 9 (45) |
| Hemoglobin <10.5 g/dL | 0 (0) | 6 (30) |
| White blood cell count >15 × 109/L) | 1 (4) | 3 (15) |
| Absolute lymphocyte count <8% or <0.6 × 109/L | 1 (4) | 1 (5) |
| Serum albumin <40 g/L | 17 (61) | 19 (95) |
All data are presented as number (percentage) unless stated otherwise.